October 1, 2019 Advanced Regenerative Medicine Institute (ARMI) features NovaSterilis in its new member spotlight. https://www.armiusa.org/news/2019/10/1/new-member-spotlight-novasterilis
November 25, 2019 The FDA chooses NovaSterilis to work directly with the FDA on new approaches to medical device sterilization focused on identifying alternatives to ethylene oxide (EtO) sterilization methods. https://www.fda.gov/medical-devices/general-hospital-devices-and-supplies/fda-innovation-challenge-1-identify-new-sterilization-methods-and-technologies
February 2, 2020 NovaSterilis technical team co-authors paper published in Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics titled “Sterilization of epidermal growth factor with supercritical carbon dioxide and peracetic acid; analysis of changes at the amino acid and protein level” https://www.sciencedirect.com/science/article/abs/pii/S1570963919302195
February 18, 2020 NovaSterilis places NovaGenesis benchtop supercritical CO2 system at Universidade de Santiago de Compostela prior to the university hosting “EIFS 2020, the First Iberian Meeting on Supercritical Fluids” https://flucomp.es/eventos/eifs2020
August 1, 2020 Surfaces in Biomaterials Foundation Summer 2020 newsletter chronicles NovaSterilis’ and iFyber’s rapid mobilization of resources to address demands for reprocessing of PPE in support healthcare providers through COVID-19 pandemic.
https://www.surfaces.org/resources/Documents/SurFACTS/2020/SurFACTS%20Summer%202020.pdf
August 21, 2020 The FDA issued an emergency use authorization (EUA) to NovaSterilis, Inc. for its Nova2200, which uses the NovaClean decontamination process. Nova2200 can be used to decontaminate compatible N95 respirators for single-user reuse by healthcare personnel (HCP) to prevent exposure to pathogenic biological airborne particulates when there are insufficient supplies of face-filtering respirators (FFRs) during the COVID-19 pandemic. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-august-21-2020
February 9, 2021 NovaSterilis will present at the Advanced Regenerative Manufacturing Institute’s workshop on March 11, 2021. The workshop topic is Scaffold Fabrication Tools and Equipment. Tony Eisenhut, CEO of NovaSterilis, will present Supercritical Carbon Dioxide: A Terminal Sterilization Solution for Bio-based Materials. Register for the event at https://www.armiusa.org/events/2021/2/11/a-template-for-the-future-of-biomanufacturing-virtual-workshop-series-zh2np
February 13, 2021 NovaSterilis working with medical device manufacturers and regulators to reduce EO emissions. https://www.packagingdigest.com/medical-packaging/medical-device-makers-see-progress-eo-sterilization
December 21, 2021 NovaSterilis and iFyber researchers collaborate with Universidade Catolica Portuguesa and Universidade Nova de Lisboa on a technology review publication that identifies contributions of supercritical fluid technology for decellularization of biological materials. https://doi.org/10.1039/D1MH01720A